Condition: Osteoarthritis · Sponsor: Eli Lilly and Company
The GZPT master protocol will support two independent studies, J2A-MC-GZT1 and J2A-MC-GZT2. Each study will see how well and safely orforglipron works in people with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the study will last about 74 weeks.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Arizona Research Center | Phoenix, Arizona, United States | Recruiting |
| AMR Clinical | Tempe, Arizona, United States | Recruiting |
| Care Access - Huntington Beach | Huntington Beach, California, United States | Recruiting |
| Care Access - Thousand Oaks | Thousand Oaks, California, United States | Recruiting |
| Legacy Clinical Trials | Colorado Springs, Colorado, United States | Recruiting |
| Chase Medical Research, LLC | Waterbury, Connecticut, United States | Recruiting |
| Care Access - Decatur | Decatur, Georgia, United States | Recruiting |
| North Georgia Clinical Research | Woodstock, Georgia, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| AMR Clinical | Newton, Kansas, United States | Recruiting |
| MedVadis Research Corporation | Waltham, Massachusetts, United States | Recruiting |
| StudyMetrix Research | City of Saint Peters, Missouri, United States | Recruiting |
+ 84 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.